Viewing Study NCT00235599



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00235599
Status: COMPLETED
Last Update Posted: 2007-05-17
First Post: 2005-10-06

Brief Title: The IGFBP-3 Stimulation Test A New Tool for the Diagnosis of Growth Hormone Deficiency in Children
Sponsor: University of Massachusetts Worcester
Organization: University of Massachusetts Worcester

Study Overview

Official Title: The Insulin-Like Growth Factor Binding Protein-3 Test A New Tool for the Diagnosis of Growth Hormone Deficiency in Children
Status: COMPLETED
Status Verified Date: 2007-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This project is designed to answer the question Is there an acute IGFBP-3 response in normal children

Our specific hypothesis states that under the influence of growth hormone secretagogues intact IGFBP-3 molecule will undergo proteolysis and liberate IGFBP-3 fragments along with other components of the ternary complex This proteolysis will result in measurable rise in IGFBP-3 which will indicate the subjects growth hormone status Short children with growth hormone deficiency will not show an IGFBP-3 response
Detailed Description: The diagnosis of growth hormone deficiency is problematic given the shortcoming of the standard growth hormone stimulation test This study is designed to investigate a new tool for the diagnosis of growth hormone deficiency

Ten short prepubertal children who fulfill the inclusion criteria will undergo a two-secretagogue standard growth hormone stimulation test and an insulin like growth factor binding protein-3 IGFBP-3 stimulation test simultaneously During this test components of the ternary complex moieties viz insulin-like growth factor-I IGF-I IGFBP-3 and acid labile subunit ALS will also be measured along with growth hormone

The aim of this study is to detect an acute rise in IGFBP-3 of 15 from baseline

The importance of this study is that it inculcates the specificity and improved sensitivity of stimulated IGFBP-3 in the diagnosis of growth hormone deficiency

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
H-11757 None None None